We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.74B
AUM Growth
+$743M
Cap. Flow
+$207M
Cap. Flow %
4.37%
Top 10 Hldgs %
17.46%
Holding
1,440
New
165
Increased
569
Reduced
526
Closed
100

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$9.67M
2
LOW icon
Lowe's Companies
LOW
+$6.73M
3
ALB icon
Albemarle
ALB
+$5.55M
4
VEEV icon
Veeva Systems
VEEV
+$5.27M
5
CHWY icon
Chewy
CHWY
+$5.11M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 11.15%
3 Financials 10.55%
4 Consumer Discretionary 9.84%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$220B
$26.2M 0.55%
56,183
-5,980
-10% -$2.8M
SBUX icon
27
Starbucks
SBUX
$120B
$25.9M 0.55%
242,017
-2,843
-1% -$271K
WMT icon
28
Walmart Inc
WMT
$890B
$25.4M 0.54%
528,825
+12,147
+2% +$590K
PFE icon
29
Pfizer
PFE
$153B
$24.4M 0.52%
663,870
-13,970
-2% -$512K
BMY icon
30
Bristol-Myers Squibb
BMY
$132B
$23.9M 0.51%
385,916
+13,440
+4% +$826K
T icon
31
AT&T
T
$163B
$23.7M 0.5%
1,091,855
+72,624
+7% +$1.57M
PEP icon
32
PepsiCo
PEP
$190B
$23.4M 0.49%
157,832
+1,930
+1% +$274K
PG icon
33
Procter & Gamble
PG
$339B
$23.3M 0.49%
167,381
+4,330
+3% +$605K
MTUM icon
34
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$23.2M 0.49%
143,628
+25,818
+22% +$3.96M
XYZ
35
Block Inc
XYZ
$47.5B
$22.5M 0.48%
103,496
+17,291
+20% +$3.37M
HON icon
36
Honeywell
HON
$78B
$21.9M 0.46%
109,378
-4,044
-4% -$735K
ZTS icon
37
Zoetis
ZTS
$30B
$21.9M 0.46%
132,488
+3,971
+3% +$646K
MRK icon
38
Merck
MRK
$318B
$21.9M 0.46%
280,580
-1,945
-0.7% -$149K
NFLX icon
39
Netflix
NFLX
$309B
$21.7M 0.46%
401,230
-370
-0.1% -$18.8K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$21.6M 0.46%
57,811
+6,924
+14% +$2.46M
CSCO icon
41
Cisco
CSCO
$479B
$20.9M 0.44%
467,802
-90,684
-16% -$3.73M
MDT icon
42
Medtronic
MDT
$112B
$20.9M 0.44%
178,645
+3,883
+2% +$427K
NEE icon
43
NextEra Energy
NEE
$177B
$20.6M 0.44%
267,257
+13,625
+5% +$1.02M
BIV icon
44
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$20.5M 0.43%
220,405
+217,551
+7,623% +$20.3M
MA icon
45
Mastercard
MA
$493B
$20M 0.42%
55,980
-2,178
-4% -$725K
GILD icon
46
Gilead Sciences
GILD
$165B
$19.8M 0.42%
339,311
-51,023
-13% -$3.08M
IBM icon
47
IBM
IBM
$224B
$19.5M 0.41%
161,899
+38,477
+31% +$4.45M
INTC icon
48
Intel
INTC
$513B
$19.4M 0.41%
390,321
-4,566
-1% -$223K
UNH icon
49
UnitedHealth
UNH
$370B
$19.2M 0.4%
54,676
-4,659
-8% -$1.56M
AMGN icon
50
Amgen
AMGN
$222B
$19M 0.4%
82,643
-779
-0.9% -$180K

Similar funds

Oppenheimer & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Oppenheimer & Co held 1,440 positions worth $4.74B, up 19% from $4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co deployed $207M of net new capital in Q4 2020, opening 165 new positions and adding to 569 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $9.67M trimmed.

  • Oppenheimer & Co's largest Q4 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.
  • Oppenheimer & Co added most to Vanguard Intermediate-Term Bond ETF in Q4 2020, an estimated $20.3M increase.
  • Oppenheimer & Co's biggest Q4 2020 reduction was ProShares Short S&P500, cutting an estimated $9.67M.
  • Oppenheimer & Co fully exited PagerDuty in Q4 2020, selling an estimated $2.96M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.74B portfolio in Q4 2020.
  • Oppenheimer & Co opened 165 new positions and closed 100 in Q4 2020.
  • Oppenheimer & Co's portfolio value rose 19% quarter-over-quarter to $4.74B.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.